SHERRI PARR: Open Payments
NPI 1336222983 · MARION, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,356 in 130 payments from 22 companies in 2025. Trend: 2023 $2,441 · 2024 $2,788 · 2025 $2,356
Food & beverage: $2,356
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $515 |
| AstraZeneca Pharmaceuticals LP | 9 | $359 |
| Novo Nordisk Inc | 17 | $254 |
| Sumitomo Pharma America, Inc. | 14 | $247 |
| PFIZER INC. | 9 | $153 |
| Axsome Therapeutics, Inc. | 8 | $146 |
| GlaxoSmithKline, LLC. | 7 | $122 |
| Lilly USA, LLC | 7 | $119 |
| Abbott Laboratories | 5 | $92 |
| Dexcom, Inc. | 3 | $66 |
Products named: GEMTESA, VRAYLAR, BREZTRI, UBRELVY, AIRSUPRA, Auvelity, Ozempic, TRELEGY ELLIPTA.
Industry payments across IL — which companies pay providers there.
